CIK 0001226616 · Non-accelerated filer<br>Smaller reporting company
MEDICINOVA INC
Sign in to watch- Ticker
- MNOV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330927979
- Phone
- 858-373-1500
- Business address
- 4275 EXECUTIVE SQUARE, SUITE 300, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,728,000
- in 1 filing
Net −$1,728,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-09 | IWAKI YUICHI President and CEO | Option exercise · Employee Stock option (Right to Buy) | −39,583 | 0 | ||
| 2021-06-24 | Matsuda Kazuko Chief Medical Officer | Option exercise | +46,554 | $2.54 | $118K | 206,746 |
| 2021-06-24 | Matsuda Kazuko Chief Medical Officer | Option exercise | +56,250 | $2.46 | $138K | 262,996 |
| 2021-06-24 | Matsuda Kazuko Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −46,554 | 0 | ||
| 2021-06-24 | Matsuda Kazuko Chief Medical Officer | Option exercise · Employee Stock Option (Right to Buy) | −56,250 | 0 | ||
| 2021-06-16 | Nagao Hideki Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-06-16 | BEAVER CAROLYN Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-05-19 | OBrien Geoffrey Vice President | Option exercise | +32,000 | $2.54 | $81K | 37,000 |
| 2021-05-19 | OBrien Geoffrey Vice President | Option exercise | +11,318 | $2.46 | $28K | 48,318 |
| 2021-05-19 | OBrien Geoffrey Vice President | Option exercise · Employee Stock Option (Right to Buy) | −32,000 | 0 | ||
| 2021-05-19 | OBrien Geoffrey Vice President | Option exercise · Employee Stock Option (Right to Buy) | −11,318 | 14,932 | ||
| 2021-04-22 | Gaeta Federico C.A. Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2021-03-11 | Nagao Hideki Director | Sale | −2,354 | $7.40 | $17K | 12,646 |
| 2021-02-25 | IWAKI YUICHI President and CEO | Option exercise | +86,250 | $2.46 | $212K | 927,350 |
| 2021-02-25 | IWAKI YUICHI President and CEO | Option exercise · Employee Stock option(Right to Buy) | −86,250 | 0 | ||
| 2021-02-02 | OBrien Geoffrey Vice President | Grant or award · Employee Stock Option (Right to Buy) | +99,000 | 99,000 | ||
| 2021-02-02 | Matsuda Kazuko Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +325,000 | 325,000 | ||
| 2021-02-02 | IWAKI YUICHI President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +495,000 | 495,000 | ||
| 2020-10-20 | BEAVER CAROLYN Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2020-09-15 | Nagao Hideki Director | Sale | −1,000 | $5.78 | $6K | 15,000 |
Page 3 of 8 · 149 trades